1. Home
  2. IMKTA vs NVCR Comparison

IMKTA vs NVCR Comparison

Compare IMKTA & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

HOLD

Current Price

$89.39

Market Cap

1.7B

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$15.43

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMKTA
NVCR
Founded
1963
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Food Chains
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
IMKTA
NVCR
Price
$89.39
$15.43
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$28.08
AVG Volume (30 Days)
133.1K
1.5M
Earning Date
05-11-2026
04-30-2026
Dividend Yield
0.74%
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$5,334,032,609.00
$655,353,000.00
Revenue This Year
N/A
$7.72
Revenue Next Year
N/A
$6.74
P/E Ratio
$15.91
N/A
Revenue Growth
N/A
8.28
52 Week Low
$59.27
$9.82
52 Week High
$95.62
$18.92

Technical Indicators

Market Signals
Indicator
IMKTA
NVCR
Relative Strength Index (RSI) 50.23 44.45
Support Level $86.11 $14.85
Resistance Level $89.76 $15.19
Average True Range (ATR) 2.34 0.87
MACD -0.18 -0.33
Stochastic Oscillator 39.47 34.89

Price Performance

Historical Comparison
IMKTA
NVCR

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: